Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
danlan xianpeng liaofu
- Development stage
- Unknown
- Lead developer
- Guiyang Runfeng Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Danlan Xianpeng Liaofu is a traditional Chinese medicine (TCM) formulation developed by Guiyang Runfeng Pharmaceutical Co., Ltd. for the treatment of endemic skeletal fluorosis, specifically targeting patients with kidney yang deficiency syndrome. Skeletal fluorosis is a chronic metabolic bone disease caused by excessive fluoride intake, leading to joint pain, stiffness, and bone deformities. The formulation's name suggests a combination of botanical extracts (likely including herbs like Salvia miltiorrhiza or Isatis tinctoria and Epimedium) with boron, a trace element investigated for its ability to interact with fluoride metabolism and mitigate its toxic effects on bone tissue. The drug has been evaluated in early-stage clinical trials in China to assess its safety and preliminary efficacy in improving symptoms and bone health in affected populations.
- Brand names
- Danlan Xianpeng Liaofu Capsule
- Other names
- 丹蓝仙硼疗氟胶囊Danlan Xianpeng Liaofu Capsule
Beyond the preview
Go deeper on danlan xianpeng liaofu.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on danlan xianpeng liaofu.